share_log

Stocks of the Hour: Findi, Immutep, ImpediMed

Stocks of the Hour: Findi, Immutep, ImpediMed

當下股票:Findi、Immutep、ImpediMed
sharecafe ·  2023/11/03 08:03

To register for today's webinar click here.

要註冊今天的網絡研討會,請單擊此處。

Findi (ASX:FND) has extended the existing State Bank of India contract until 30 September 2024. Commenting on the SBI contract extension, Findi Chairman Mr Nicholas Smedley said: "The SBI contract extension combined with the improved terms of the new SBI contact announced on 30 October will enable Findi to deliver significant organic growth over coming years. Shares are trading 10 per cent higher at 77 cents.

Findi (ASX: FND) 已將印度國家銀行的現有合同延長至2024年9月30日。Findi董事長尼古拉斯·斯梅德利在評論SBI合同延期時說:“SBI合同的延期,加上10月30日宣佈的SBI新合同條款的改進,將使Findi能夠在未來幾年實現顯著的有機增長。股價上漲10%,至77美分。

Immutep (ASX:IMM) has announced new biomarker data from the TACTI-002 Phase II trial evaluating efti. The data shows statistically significant increases of Th1 biomarkers, circulating immune cells, and RNA levels of immune activating genes were observed and linked to improved clinical outcomes. Shares are trading 5 per cent higher 31.5 cents.

Immutep (ASX: IMM) 公佈了評估efti的 TACTI-002 II期試驗的新生物標誌物數據。數據顯示,觀察到Th1生物標誌物、循環免疫細胞和免疫激活基因的RNA水平在統計學上顯著增加,這與臨床結果的改善有關。股價上漲5%,上漲31.5美分。

ImpediMed (ASX:IPD) announced that UnitedHealthcare, the largest US private payor updates the medical policy for BIS. In response, Rick Valencia, Managing Director and CEO of ImpediMed, stated, "this is a very exciting step for patients at risk of lymphoedema. We expect this change to mean that we will have silent coverage from UnitedHealthcare, when the policy goes into effect in January 2024. With this change, UnitedHealthcare will be the second Top 5 national payor to cover SOZO testing for lymphoedema. Cigna was the first." Shares are trading 8.7 per cent higher at 12.5 cents.

ImpediMed(澳大利亞證券交易所股票代碼:IPD)宣佈,美國最大的私人支付機構UnitedHealthcare更新了BIS的醫療政策。對此,ImpediMed董事總經理兼首席執行官裏克·瓦倫西亞表示:“對於有淋巴水腫風險的患者來說,這是非常激動人心的一步。我們預計,這一變化將意味着,當該政策於2024年1月生效時,我們將獲得UnitedHealthcare的無聲保險。有了這一變化,UnitedHealthcare將成爲第二家承保SOZO淋巴水腫檢測的全國前五名支付機構。信諾是第一個。”股價上漲8.7%,至12.5美分。

1x1.png?futu_img_keep_extra_domain=1

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論